Convinced Anthropic's COBOL Coding Could Hinder IBM
The market loves dramatic headlines about AI threatening legacy tech, but the real story is nuanced. This piece expla...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesThe market loves dramatic headlines about AI threatening legacy tech, but the real story is nuanced. This piece expla...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Netflix charts a high-stakes path, slowing buybacks to fund a debt-heavy growth plan and weighing a marquee deal, as ...
Finance of America reported a profitable first quarter, reversing Q4 losses as originations climbed and portfolio gai...
Lucid fans and skeptics watched the Gravity SUV as a potential turning point. When production snags and a rear-seat r...
A notable fund just built a fresh position in a cloud security leader. Discover the numbers behind winmill loads qual...
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Imagine a SpaceX-scale IPO changing how investors price AI startups. This article breaks down what spacex just bigges...
AI momentum has shifted, and Cerebras stock's volatility comes into sharper focus for investors. This guide breaks do...
China’s Kimi K3 arrives in the crypto AI arena with benchmark wins that outpace Claude Fable and GPT 5.6 Sol. This ar...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
A wave of AI anxiety moved from online whispers to market headlines this week, forcing households to rethink budgets,...